Clinical Trial Update: Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial [Phase 2, Phase 3]

View source ↗

Summary

The RAPTOR trial is evaluating the addition of radiation therapy to atezolizumab for extensive-stage small cell lung cancer and is currently recruiting for Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (Tecentriq) (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Lung Small Cell Carcinoma | Phase 2, Phase 3 | Status: RECRUITING